论文部分内容阅读
IN-CROSS研究亚组分析是对之前进行的研究数据进行了析因分析。试验入选患者和分组方法见文献[1]。对总人群和是否患有2型糖尿病(T2DM)的患者(符合下列1项以上标准者被列为T2DM患者:既往诊断为T2DM;使用降糖治疗;空腹血糖水平≥126 mg/dl),均进行了疗效和安全
The IN-CROSS study subgroup analysis conducted a factorial analysis of previously performed study data. The trial selected patients and grouping method [1]. Patients in the general population and in patients with type 2 diabetes mellitus (T2DM) (those with one or more of the following criteria were classified as T2DM: previously diagnosed with T2DM; treated with hypoglycemic therapy; and had fasting glucose levels ≥126 mg / dl) Efficacy and safety